3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
16
Lymphoma, Large B-Cell, Diffuse
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, Follicular
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, B-Cell
4
Lymphoma
4
Wilms Tumor
3
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Down Syndrome
3
Plasmablastic Lymphoma
2
Medulloblastoma
2
Lymphoproliferative Disorders
2
Lymphoma, B-Cell, Marginal Zone
2
Ganglioneuroblastoma
2
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdoid Tumor
1
Osteosarcoma
1
Neuroblastoma
1
Multi-centric Castleman's Disease
1
Malignant mesenchymal tumor
1
Macular dystrophy, corneal type 1
1
Interventions
Cyclophosphamide
8
asciminib
7
fludarabine phosphate
6
fludarabine
5
Mycophenolic Acid
5
nilotinib
3
Whole-Body Irradiation
3
Thiotepa
3
Tacrolimus
3
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporine
3
venetoclax
2
Sirolimus
2
Melphalan
2
Filgrastim
2
Dasatinib
2
Cyclosporins
2
treosulfan
1
thymoglobulin
1
selinexor
1
ruxolitinib
1
ponatinib
1
plerixafor
1
olverembatinib
1
midostaurin
1
merphos
1
gilteritinib
1
bosutinib
1
blinatumomab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Vincristine
×
30 days
×
Clear all
No trials found.